Search Results - "Akehi, Masaru"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Novel single‐chain variant of antibody against mesothelin established by phage library by Yakushiji, Hiromasa, Kobayashi, Kazuko, Takenaka, Fumiaki, Kishi, Yoshiro, Shinohara, Midori, Akehi, Masaru, Sasaki, Takanori, Ohno, Eiji, Matsuura, Eiji

    Published in Cancer science (01-09-2019)
    “…Mesothelin (MSLN) shows increased expression in various cancer cells. For clinical application of antibodies as a positron emission tomography (PET) imaging…”
    Get full text
    Journal Article
  2. 2

    Fluorine-18 (18F)-labeled retinoid x receptor (RXR) partial agonist whose tissue transferability is affected by other RXR ligands by Takamura, Yuta, Shibahara, Osamu, Watanabe, Masaki, Fujihara, Michiko, Yamada, Shoya, Akehi, Masaru, Sasaki, Takanori, Hirano, Hiroyuki, Kakuta, Hiroki

    Published in Bioorganic & medicinal chemistry (15-07-2019)
    “…[Display omitted] Bexarotene (1), a retinoid X receptor (RXR) agonist approved for the treatment of cutaneous T cell lymphoma (CTCL), was reported to migrate…”
    Get full text
    Journal Article
  3. 3

    Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect by Fithroni, Abdul Basith, Kobayashi, Kazuko, Uji, Hirotaka, Ishimoto, Manabu, Akehi, Masaru, Ohtsuki, Takashi, Matsuura, Eiji

    Published in Cells (Basel, Switzerland) (01-10-2022)
    “…BNCT is a non-invasive cancer therapy that allows for cancer cell death without harming adjacent cells. However, the application is limited, owing to the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Positron Emission Tomography to Elucidate Pharmacokinetic Differences of Regioisomeric Retinoid X Receptor Agonists by Kobayashi, Toshiki, Furusawa, Yuki, Yamada, Shoya, Akehi, Masaru, Takenaka, Fumiaki, Sasaki, Takanori, Akahoshi, Akiya, Hanada, Takahisa, Matsuura, Eiji, Hirano, Hiroyuki, Tai, Akihiro, Kakuta, Hiroki

    Published in ACS medicinal chemistry letters (12-03-2015)
    “…RXR partial agonist NEt-4IB (2a, 6-[ethyl-(4-isobutoxy-3-isopropylphenyl)amino]pyridine-3-carboxylic acid: EC50 = 169 nM, E max = 55%) showed a blood…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The Function of β2-glycoprotein I in Angiogenesis and Its in Vivo Distribution in Tumor Xenografts by Wahyuningsih, Arum Tri, Shen, Lianhua, Kobayashi, Kazuko, Sasaki, Takanori, Takenaka, Fumiaki, Hanada, Takahisa, Akehi, Masaru, Akahoshi, Akiya, Ozeki, Eiichi, Ando, Eiji, Matsuura, Eiji

    Published in Acta medica Okayama (2016)
    “…Intact β2-glycoprotein I (iβ2GPI) is a glycoprotein that regulates coagulation and fibrinolysis. Nicked β2GPI (nβ2GPI) possesses an angiogenic property at a…”
    Get full text
    Journal Article
  11. 11

    Chiral 1-(1,3-dithian-2-yl) prop-2-en-1-ols: new scaffolds for enantiopure α-hydroxyaldehydes by Akehi, Masaru, Kawamoto, Mariko, Mandai, Tadakatsu

    Published in Tetrahedron (16-09-2015)
    “…We have demonstrated that chiral 1-(1,3-dithian-2-yl)prop-2-en-1-ols as new scaffolds, obtained by enzyme-catalyzed kinetic resolution, undergo Suzuki-Miyaura…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Teratogenicity and Fetal-Transfer Assessment of the Retinoid X Receptor Agonist Bexarotene by Takamura, Yuta, Kato, Izumi, Fujita-Takahashi, Manami, Azuma-Nishii, Midori, Watanabe, Masaki, Nozaki, Rui, Akehi, Masaru, Sasaki, Takanori, Hirano, Hiroyuki, Kakuta, Hiroki

    Published in ACS pharmacology & translational science (09-09-2022)
    “…Bexarotene, a retinoid X receptor (RXR) agonist, is used to treat cutaneous T-cell lymphoma, and drug repositioning research has also been reported, despite…”
    Get full text
    Journal Article
  15. 15
  16. 16